IDO1 抗体 (AA 1-403)
Quick Overview for IDO1 抗体 (AA 1-403) (ABIN7115217)
抗原
See all IDO1 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 1-403
-
原理
- IDO1 antibody
-
纯化方法
- Immunogen affinity purified
-
纯度
- ≥95 % as determined by SDS-PAGE
-
免疫原
-
Immunogen sequence: 1-403aa,full length
Immunogen: indoleamine 2,3-dioxygenase 1
-
亚型
- IgG
-
-
-
-
应用备注
- WB: 1:1000-1:4000, IHC: 1:50-1:500
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
- Avoid repeated freeze / thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- -20°C for 12 months
-
有效期
- 12 months
-
-
- IDO1 (Indoleamine 2,3-Dioxygenase 1 (IDO1))
-
别名
- IDO1
-
背景
-
Synonyms: Indoleamine 2,3-dioxygenase 1 (IDO-1)|Indoleamine-pyrrole 2,3-dioxygenase|IDO1|IDO|INDO
Background: Catalyzes the first and rate limiting step of the catabolism of the essential amino acid tryptophan along the kynurenine pathway(PubMed:17671174). Involved in the peripheral immune tolerance, contributing to maintain homeostasis by preventing autoimmunity or immunopathology that would result from uncontrolled and overreacting immune responses(PubMed:25691885). Tryptophan shortage inhibits T lymphocytes division and accumulation of tryptophan catabolites induces T-cell apoptosis and differentiation of regulatory T-cells(PubMed:25691885). Acts as a suppressor of anti-tumor immunity(PubMed:23103127, PubMed:25157255, PubMed:14502282, PubMed:25691885). Limits the growth of intracellular pathogens by depriving tryptophan(PubMed:25691885). Protects the fetus from maternal immune rejection(PubMed:25691885).
-
分子量
- 42 kDa
-
基因ID
- 3620
-
UniProt
- P14902
-
途径
- Activated T Cell Proliferation
抗原
-